Shattuck Labs (STTK) Stock Price

Shattuck Labs Price

NASDAQ·CLOSED
5.64
​
Market closed

Revenue at Shattuck Labs has contracted by 35.9% per year over the past 7 years to 1.00 M USD. For Shattuck Labs, the net margin of -4,880.9% is down versus -149.8% a few years ago. The consensus 12-month price target for Shattuck Labs is 12.50 USD, about 121.6% above where the stock trades today. Of 17 analysts, 16 rate the stock a buy — an overall Buy consensus.

Shattuck Labs stock price

Access this data via the Eulerpool API

Shattuck Labs business model & stock analysis

Shattuck Labs, Inc. engages in the research and development of dual-sided fusion proteins used for medical treatment of cancer and autoimmune disease. The company is headquartered in Austin, Texas and currently employs 105 full-time employees. The company went IPO on 2020-10-09. The firm is engaged in the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease. Its lead product candidate, SL-172154, is designed to simultaneously inhibit the CD47/SIRPa macrophage checkpoint interaction and activate the CD40 costimulatory receptor to induce an antitumor immune response. SL-172154 is in an ongoing Phase I clinical trial for the treatment of patients with ovarian cancer. The company is also evaluating SL-172154 in an ongoing Phase I clinical trial for the treatment of patients with certain hematologic malignancies, including acute myeloid leukemia (AML), and higher-risk myelodysplastic syndromes (HR-MDS). The firm is also advancing a Gamma Delta T Cell Engager, GADLEN platform, which is designed to bridge gamma delta T cells to tumor antigens for the treatment of patients with cancer.

Frequently asked questions about Shattuck Labs

Analysts currently set an average price target of 12.00 USD for the Shattuck Labs stock (median: 12.50 USD), implying +112.8 % versus the latest price. The consensus is based on 17 analyst ratings.

17 analysts currently rate the Shattuck Labs stock: 16 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Shattuck Labs to generate revenue of 105,000.00 USD and earnings per share of -0.33 USD.

Converted at the current exchange rate, the Shattuck Labs share trades at 5.03 EUR (5.64 USD).

The Shattuck Labs share (STTK) is listed on 1 stock exchanges, including: NASDAQ (STTK).

The expected revenue of Shattuck Labs is 105,000.00 USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Shattuck Labs is -34.31 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Shattuck Labs is currently -17.06. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Shattuck Labs stock.

The price-to-sales ratio (P/S) of Shattuck Labs is currently 5,574.60. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Shattuck Labs stock.

The Eulerpool Quality Score for Shattuck Labs is 3/10.

The ISIN of Shattuck Labs is US82024L1035. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Shattuck Labs is STTK. The ticker symbol is used to trade Shattuck Labs shares on the stock exchange.

Fair ValueTerminal
5.75 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue per Employee
25,000.00 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Currency
USD
Initial public offering
Oct 9, 2020
ISIN
US82024L1035
Cusip
82024L103
Market capitalization
392.46 M USDSmall Cap
52-Week Range
PEG
-0.81
P/E ratio
P/Ee 2026
-17.06
P/Ee 2027
-15.77
P/Ee 2028
-13.87
P/Ee 2029
-12.05
P/Ee 2030
-8.54
P/Se
5,574.60
EV/EBIT
—
P/B Ratio
4.76
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-59.24 %
Last updated Oct 11, 2026, 12:11 AM

Shattuck Labs Peer Group

Shattuck Labs Ticker

NASDAQ · STTK

Shattuck Labs FIGI

STTK:US · BBG00V776CQ7STTK:UA · BBG00XH5SVF2STTK:UC · BBG00XH5SVG1STTK:UN · BBG00XH5SVJ8STTK:UP · BBG00XH5SVK6STTK:UB · BBG00XH5SVM4STTK:UM · BBG00XH5SVP1STTK:UX · BBG00XH5SVQ0STTK:UD · BBG00XH5SVW3STTK:UW · BBG00XH5SVY1STTK:UF · BBG00XH5SVZ0STTK:VY · BBG00XH5SW06